[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

PROCAARE: Re: RFI--Topical and herbal Medicine in Kaposi's Sarcoma


  • From: procaare@usa.healthnet.org
  • Date: Tue, 16 Dec 1997 15:26:16 -0500 (EST)


Good morning to Zambia and Dr. Nkandu - Ligand Pharmaceuticals in USA has
reported positive results in topical treatment of Kaposi's sarcoma using a drug
called Panretin gel with 31% of patients` showing complete or partial
disappearance of lesions compared with 17% on placebo. It is probable about 3-6
mo away from FDA approval at which time I could provide for you - as you would
probably guess the price will probably be restrictive as to the patients who
could afford.
Andy Canada, Ph.D.
canad002@mc.duke.edu
GLOBALRx

Give my best to Dr's Zulu and Kasonde

KEYWORDS: RFI, OPPORTUNISTIC INFECTION, KAPOSI'S SARCOMA, TOPICAL THERAPY,
PANRETIN
--
Send mail for the `ProCAARE' conference to `procaare@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-procaare@usa.healthnet.org'.